Pacific Biosciences Downgraded to Underweight with PT of $1.5 by Barclays

viernes, 6 de marzo de 2026, 9:19 am ET1 min de lectura
PACB--

Pacific Biosciences Downgraded to Underweight with PT of $1.5 by Barclays

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios